ASSENT 1
Assessment of the Safety of a New Thrombolytic: TNK-tPA

Purpose
To evaluate the safety of TNK-tPA in subjects with acute MI presenting within 12 h after onset of symptoms

References
The trial design has not been published

Voltar

Apoio: Libbs Farmacêutica Farmacêutica